Search bioRxiv⌕ Search

Biology subjects

Hunsberger, H.

Publications and source records attributed to Hunsberger, H..

2 recordsLinked to original sources

Alprazolam induces anterograde amnesia for contextual fear memory and alters dorsoventral hippocampal neuronal ensembles in female mice

Benzodiazepines (BZDs) are commonly prescribed anxiolytic drugs that act on GABAa receptors, and can result in anterograde amnesia, or the inability to form new memories. While BZDs have been used for decades, the brain regions and neuronal mechanisms responsible for this detrimental side effect are largely unknown at the systems neuroscience level. To analyze the effects of BZDs on long-term memory, activity-dependent ArcCreERT2 x eYFP mice were injected with Alprazolam 30 minutes prior to a 3-shock contextual fear conditioning (CFC) procedure and encoding ensembles were tagged with eYFP. Mice were re-exposed to the same context 5 days later, and retrieval cell activation was analyzed using the immediate early gene (IEG), c-Fos, allowing us to determine which brain regions undergo changes after alprazolam injection. Additionally, we address the question of whether alprazolam induces state-dependent memory by altering the timelines of injection. We found that 1) alprazolam treated male and female mice exhibit a decrease in memory retention and, 2) alprazolam treated female and male mice show a decrease in memory retention with saline injection prior to re-exposure, 3) alprazolam treated female mice exhibit increased EYFP+ (encoding) activation in the dCA1 and enhanced engram activation in the dCA3, and 4) alprazolam treated females showed less c-Fos+ activation in the vCA1. These results suggest that alprazolam induces sex-specific ensemble activation throughout the hippocampus and will help us understand the long-term memory deficits associated with BZD use.

neuroscience↗

Sex-Specific Effects of Anxiety on Cognition and Activity-Dependent Neural Networks: Insights from (Female) Mice and (Wo)Men

INTRODUCTIONNeuropsychiatric symptoms (NPS), such as depression and anxiety, are observed in 90% of Alzheimers disease (AD) patients, two-thirds of whom are women. NPS usually manifest long before AD onset creating a therapeutic opportunity. Here, we examined the impact of anxiety on AD progression and the underlying brain-wide neuronal mechanisms. METHODSTo gain mechanistic insight into how anxiety impacts AD progression, we performed a cross-sectional analysis on mood, cognition, and neural activity utilizing the ArcCreERT2 x enhanced yellow fluorescent protein (eYFP) x APP/PS1 (AD) mice. The ADNI dataset was used to determine the impact of anxiety on AD progression in human subjects. RESULTSFemale AD mice exhibited anxiety-like behavior and cognitive decline at an earlier age than control (Ctrl) mice and male mice. Brain-wide analysis of c-Fos+ revealed changes in regional correlations and overall network connectivity in AD mice. Sex-specific memory trace changes were observed; female AD mice exhibited impaired memory traces in dorsal CA3 (dCA3), while male AD mice exhibited impaired memory traces in the dorsal dentate gyrus (dDG). In the ADNI dataset, anxiety predicted transition to dementia. Female subjects positive for anxiety and amyloid transitioned more quickly to dementia than male subjects. CONCLUSIONSWhile future studies are needed to understand whether anxiety is a predictor, a neuropsychiatric biomarker, or a comorbid symptom that occurs during disease onset, these results suggest that AD network dysfunction is sexually dimorphic, and that personalized medicine may benefit male and female AD patients rather than a one size fits all approach.

neuroscience↗